| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/28/2011 | US20110183900 High Caloric Enteral Formulations |
| 07/28/2011 | US20110183899 Methods and compositions for the treatment of obesity |
| 07/28/2011 | US20110183897 Variant activin receptor polypeptides |
| 07/28/2011 | US20110183889 Salicylanilide modified peptides for use as oral therapeutics |
| 07/28/2011 | US20110183888 Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases |
| 07/28/2011 | US20110183886 Melanocortin receptor ligands |
| 07/28/2011 | US20110183020 Preparation, process and a regenerative method and technique for prevention, treatment and glycemic control of diabetes mellitus |
| 07/28/2011 | US20110183008 Lactoferrin |
| 07/28/2011 | US20110182983 Human immortalised neural precursor cell line |
| 07/28/2011 | US20110182979 In-Vivo Non-Viral Gene Delivery of Human Vascular Endothelial Growth Factor Following Islet Transplantation |
| 07/28/2011 | US20110182930 Large-scale process for the preparation of thylakoids |
| 07/28/2011 | US20110182922 Peptides of il1 beta and tnf alpha and method of treatment using same |
| 07/28/2011 | US20110182920 Identification of a novel cysteine-rich cell penetrating peptide |
| 07/28/2011 | US20110182894 Methods of treating diabetes using IL-1beta antibodies |
| 07/28/2011 | US20110182893 Prevention and treatment of amyloidogenic diseases |
| 07/28/2011 | US20110182889 Compositions and methods for the treatment of natural killer cell related diseases |
| 07/28/2011 | US20110182883 Novel gene disruptions, compositions and methods relating thereto |
| 07/28/2011 | CA2825137A1 Methods of treating or preventing periodontitis and diseases associated with periodontitis |
| 07/28/2011 | CA2792993A1 Special composition for the use thereof as a drug |
| 07/28/2011 | CA2787248A1 Piperazine compound having a pgds inhibitory effect |
| 07/28/2011 | CA2787131A1 Pharmaceutical composition for treating a metabolic syndrome |
| 07/28/2011 | CA2786520A1 Pyrazine derivatives |
| 07/28/2011 | CA2786162A1 4-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compounds |
| 07/27/2011 | EP2348106A1 Chimeric proteins, cells comprising same, and assays using same |
| 07/27/2011 | EP2348050A1 Anti-glycated CD59 antibodies and uses thereof |
| 07/27/2011 | EP2348047A1 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same |
| 07/27/2011 | EP2348019A1 1,2-diazetidin-3-one derivative and pharmaceutical agent comprising same |
| 07/27/2011 | EP2348018A1 Heterocyclic biaryl derivative, and pde inhibitor comprising same as active ingredient |
| 07/27/2011 | EP2347766A1 Use of TNFalpha antibodies and another drug |
| 07/27/2011 | EP2347762A1 Exendin for treating diabetes and reducing body weight |
| 07/27/2011 | EP2347758A1 Process for obtaining a composition of rosuvastatin calcium and product obtained |
| 07/27/2011 | EP2347660A1 Composition for promoting control of total and ldl cholesterol and/or weight loss and/or thermogenesis |
| 07/27/2011 | EP2346906A1 Conjugates of glp-1 agonists and uses thereof |
| 07/27/2011 | EP2346873A1 Azolopyrrolone melanin concentrating hormone receptor-1 antagonists |
| 07/27/2011 | EP2346872A1 Azolotriazinone melanin concentrating hormone receptor-1 antagonists |
| 07/27/2011 | EP2346860A1 Pyrrolone melanin concentrating hormone receptor-1 antagonists |
| 07/27/2011 | EP2346853A2 Inhibitors of diacylglycerol acyltransferase |
| 07/27/2011 | EP2346834A1 3-amino-indazole or 3-amino-4,5,6,7-tetrahydro-indazole derivatives |
| 07/27/2011 | EP2346522A1 Methods of modulating protein homeostasis, metabolic syndrome, heavy metal intoxication and nrf2 transcription factors |
| 07/27/2011 | EP2346504A1 Combinations comprising bicyclic s1p lyase inhibitors |
| 07/27/2011 | EP2346498A1 Methods of reducing small, dense ldl particles |
| 07/27/2011 | EP2040702B1 Use of ampk-activating imidazole derivatives, preparation process therefor and pharmaceutical compositions comprising them |
| 07/27/2011 | EP1638964B1 Novel compounds that modulate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 07/27/2011 | EP1598349B1 Novel 2-pyridinecarboxamide derivatives |
| 07/27/2011 | EP1490355B1 Indolylmaleimide derivatives |
| 07/27/2011 | CN201906228U Composite structure of medicine for treating type II diabetes |
| 07/27/2011 | CN1309666B Polymer composition of glucuronic acid glucosan |
| 07/27/2011 | CN102137864A Fused pyrrolidino-cyclopropane derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors |
| 07/27/2011 | CN102137863A Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| 07/27/2011 | CN102137862A Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| 07/27/2011 | CN102137854A 4-(pyridin-4-yl)-1H-[1,3,5]triazin-2-one derivatives as GSK3-beta inhibitors for the treatment of neurodegenerative diseases |
| 07/27/2011 | CN102137844A Compounds and compositions as modulators of GPR119 activity |
| 07/27/2011 | CN102137836A Compounds for the treatment of metabolic diseases |
| 07/27/2011 | CN102137668A Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| 07/27/2011 | CN102137662A Novel epigallocatechin gallate trimer, and alpha-glucosidase inhibitor comprising epigallocatechin gallate polymer |
| 07/27/2011 | CN102134312A Amphipathic compound of curcumin derivates and polyoxyethylene as well as preparation method and application thereof |
| 07/27/2011 | CN102134274A tGLP-1 derivative as well as preparation and application thereof |
| 07/27/2011 | CN102134234A Indazolyl urea compounds and preparation method and medicinal use thereof |
| 07/27/2011 | CN102134231A Dipeptidyl peptidase inhibitors |
| 07/27/2011 | CN102134230A Dipeptidyl peptidase inhibitors |
| 07/27/2011 | CN102134229A Dipeptidyl peptidase inhibitors |
| 07/27/2011 | CN102134226A Phenyl C-glucoside derivatives, preparation method and use thereof |
| 07/27/2011 | CN102133416A Compound protein air-purifying deodorizer (deodorant liquid) |
| 07/27/2011 | CN102133402A Application of cystic fibrosis transmembrane transduction regulating factor inhibitor to preparation of medicaments for treating diabetes |
| 07/27/2011 | CN102133394A Compound insulin preparation |
| 07/27/2011 | CN102133393A Acidic insulin preparations with improved stability |
| 07/27/2011 | CN102133390A Calcium tablets and production process |
| 07/27/2011 | CN102133377A Quality detection method of capsule for reducing blood fat and activating collaterals |
| 07/27/2011 | CN102133308A Capsule for removing toxin and eliminating fat |
| 07/27/2011 | CN102133306A Health-care medicine or medicine composition for reducing blood fat to prevent and cure heart cerebrovascular diseases and application thereof |
| 07/27/2011 | CN102133298A Two-aqueous-phase method for extracting total saponin from bittersweet herb |
| 07/27/2011 | CN102133273A Traditional Chinese medicine lipid-lowing and aperient capsule and preparation method thereof |
| 07/27/2011 | CN102133258A Extracting and purifying process of pongamia pinnata flavonoids |
| 07/27/2011 | CN102133252A Preparation method of footbath agent rich in selenium and chromium |
| 07/27/2011 | CN102133247A Costustoot extractive with blood sugar reduction activity and application thereof |
| 07/27/2011 | CN102133237A Propolis flavone soft capsule and preparation method thereof |
| 07/27/2011 | CN102133231A Product prepared by shark cartilage for supplementing calcium and promoting metabolism and development of cartilage and preparation method thereof |
| 07/27/2011 | CN102133230A Compound mactra veneriformis organic calcium preparation and preparation method thereof |
| 07/27/2011 | CN102133225A Compound polyethylene glycol electrolyte pulvis and preparation method thereof |
| 07/27/2011 | CN102133221A Compound traditional Chinese medicine extract preventing glucose metabolism disturbance and preparation method thereof |
| 07/27/2011 | CN102133205A Preparation method of glipizide osmotic pump controlled release tablet |
| 07/27/2011 | CN102133204A Preparation method of melbinum osmotic pump controlled release tablets |
| 07/27/2011 | CN102133196A Potassium ion binding polymers for pharmaceutical compositions |
| 07/27/2011 | CN102133187A Pravastatin sodium liposome solid preparation |
| 07/27/2011 | CN101843857B Chinese medicament for treating diabetic eyeground pathological changes |
| 07/27/2011 | CN101843837B Chinese medicament for treating diabetic oculopathy |
| 07/27/2011 | CN101711844B Chinese medicinal composition for relieving stagnation and freeing network vessels |
| 07/27/2011 | CN101658588B Traditional Chinese medicine composition and preparation method thereof |
| 07/27/2011 | CN101649261B Method for preparing natural detergent by using balsam pear and application thereof |
| 07/27/2011 | CN101627978B Glipizide sustained-release capsule formulation and preparation method thereof |
| 07/27/2011 | CN101584772B Traditional Chinese medicine for treating diabetes surrounding nerve lesion |
| 07/27/2011 | CN101574418B Traditional Chinese medicine tea for treating high blood pressure, hyperlipoidemia and hyperglycosemia |
| 07/27/2011 | CN101559274B Health care running machine and method for processing felt thereon |
| 07/27/2011 | CN101480398B Use of ivabradine for the treatment of endothelial dysfunction |
| 07/27/2011 | CN101475613B Method for extracting rhaponticin from Rumex plant |
| 07/27/2011 | CN101463078B Exendin-4 derivative and solid phase chemical synthesis thereof |
| 07/27/2011 | CN101402681B Polypeptide from deer floral disc, preparing method and uses for preventing and treating diabetes |
| 07/27/2011 | CN101385714B Preparation method of DHA lipid nano-particles |
| 07/27/2011 | CN101380311B Diabecron sustained-release tablet and preparation method thereof |
| 07/27/2011 | CN101366712B Method for preparing fat-soluble vitamin for injection |